Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV

Funded by the National Institute on Drug Abuse as a Center of Excellence

Learn about us Publications & Presentations Subscribe
Center for Health Economics of Treatment for Substance Users Is Established at Weill Cornell Medical College Read more

New Medicare Payment Option for Behavioral Health Integration

by Sarah Gutkind and Bruce Schackman

Medicare rang in the new year with four new codes to reimburse primary care teams for behavioral health services. According to an article that appeared in the New England Journal of Medicine on February 2, 2017, three of the codes support services using the Collaborative Care Model (CoCM) and the fourth allows for services provided […]

Read the blog post

CHERISH director Dr. Schackman presents research on economic evaluations of screening and linkage to care interventions.

Read more

Pilot grant awardee Dr. Karen Lasser and her team have developed an intervention to screen, link and treat patients with hepatitis C (HCV) in the primary care setting. As the founding medical director for HCV treatment in primary care, Dr. Lasser was motivated to do a budget impact analysis of their intervention to analyze whether the […]

Read the blog post

The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) was profiled at the Liver Meeting® 2016 in Boston, MA. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and […]

Read the full story


Answering the Call: Facing Addiction in America

by Sarah Gutkind and Julia Mitchell

Last week the Surgeon General, Dr. Vivek Murthy, released the groundbreaking, comprehensive report Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. The report comes at a critical juncture, with more than 27 million Americans misusing illicit and prescription drugs, and more than 66 million misusing alcohol. The Surgeon General details […]

Read the blog post


Hepatitis C and HIV in Substance Use: Economics of Screening and Linkage to Care

Tuesday, February 21, 2017
2:00 pm — 3:00 pm
Bruce R. Schackman, PhD, MBA


Experts in cost benefit, cost effectiveness, and budget impact analyses

Learn More Consultation Request


Experts in economic analysis of HCV and HIV and treatment among substance users

Learn More Consultation Request

Dissemination and Policy

Experts in disseminating health economic research among policy makers and the public

Learn More Latest Issue Brief

Pilot Grant and Training

Supports new investigators and investigators new to health economic research in substance use disorders, HCV, and HIV

Learn More Pilot Grants